Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0670
+0.0020 (3.08%)
Sep 11, 2026, 10:35 AM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 68.35 million as of September 10, 2026. Its market cap has increased by 62.50% in one year.
Market Cap
68.35M
Enterprise Value
59.52M
Revenue
3.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 68.35M, an increase of 1,093.96%. That is a compound annual growth rate of 9.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 68.35M | -22.62% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 110.34M |
| Recce Pharmaceuticals | 108.55M |
| Avecho Biotechnology | 88.87M |
| LTR Pharma | 84.53M |
| Arovella Therapeutics | 72.53M |
| Entropy Neurodynamics | 68.57M |
| Immutep | 67.79M |
| Amplia Therapeutics | 66.73M |